A therapy candidate for fatal prion diseases turns off disease-causing gene
Broad Institute
JUNE 27, 2024
The first problem they had to tackle was the editor’s size, because the editor needs to be small enough to be packaged and delivered to specific cells in the body. From tool to drug Led by Neumann and Bertozzi, the researchers began engineering a new epigenome editor.
Let's personalize your content